Pregnant women mount strong immune response to single H1N1 flu vaccine dose
3 Nov 2009, 1320 Hrs

Add comment          Mail          Print          Write to Editor

Washington, Nov 3 Healthy pregnant women tend to develop a strong immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial.

Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, the trial involved a preliminary analysis of blood samples taken 21 days post-vaccination from a subgroup of 50 pregnant women.

"For pregnant women, who are among the most vulnerable to serious health problems from 2009 H1N1 infection, these initial results are very reassuring," said NIAID Director Dr. Anthony S. Fauci.

"The immune responses seen in these healthy pregnant women are comparable to those seen in healthy adults at the same time point after a single vaccination, and the vaccine has been well tolerated," he added.

The researchers found that in 25 women who received a single 15-microgram dose of the vaccine, the H1N1 flu vaccine elicited an immune response likely to be protective in 92 percent, or 23 of 25, of these women.

In 25 women who received a single 30-microgram dose of the vaccine, the H1N1 flu vaccine elicited an immune response likely to be protective in 96 percent, or 24 of 25, of these women.

The trial began on Sept. 9 and reached its target enrollment of 120 volunteers in mid-October.

All participants are between 18 to 39 years old and began the study in their second or third trimester (14 to 34 weeks) of pregnancy.

On entering the study, the participants were divided at random into two groups: half are receiving two doses of a 15-microgram vaccine and the other half are receiving two doses of a 30-microgram vaccine.

The two injections of vaccine are spaced three weeks apart.

Safety is being monitored closely in the trial, by the study investigators and by an independent panel of experts known as a safety monitoring committee.

To date, the vaccine appears to be well tolerated, and no safety concerns related to the vaccine have arisen. (ANI)

Related Latest

Eight killed as strong winds lash snow-bound Rohtang Pass Nearly 50 percent of Indian women marry before 18: Unicef More women should be associated with self-help groups: Rahul Gandhi HIV infected women sell nutritious food items in Gujarat First women navigators commissioned in Indian Navy First Indian Navy women aviators take charge H1N1 riskier than regular flu for asthmatic kids: Study Many pregnant African women avoid HIV screening Husband on the run after setting pregnant wife on fire India's swine flu toll touches 537, over 16,000 affected

Related Latest

Gas explosion traps 139 coal miners in north-east China Top global jazz musicians to play in capital Green lifestyle statement: Bangalore kids cycle to school Mumbai remains extremely vulnerable: Shobhaa De (One Year After 26/11) A show that will go into people's past lives Now terrorists emerge from educated households: Om Puri US health reforms face biggest test yet in Senate Fire destroys 106 homes in Ecuador Honduras' Micheletti's temporary step down a 'positive step': US Lopez, Anthony sued over dog's behaviour

• Gas explosion traps 139 coal miners in north-east China
• Top global jazz musicians to play in capital
• Green lifestyle statement: Bangalore kids cycle to school
• Mumbai remains extremely vulnerable: Shobhaa De (One Year After 26/11)
• A show that will go into people's past lives

• भारतीय क्रिकेट की मजबूत दीवार
• कंगारूओं के आगे ढेर, चीतों से कैसे मुकाबला करेंगें शेर
• Reducing greenhouse gases may not be enough to slow global warming
• बीकानेर महापौर चुनावः एक विश्लेषण
• Deepawali: The Festival Of Lights